QOSHE - Study shows Wegovy easing heart failure symptoms for patients with diabetes—helpful to Novo Nordisk as it makes case insurers should pay for the weight-loss medication - Naomi Kresge
menu_open
Columnists Actual . Favourites . Archive
We use cookies to provide some features and experiences in QOSHE

More information  .  Close
Aa Aa Aa
- A +

Study shows Wegovy easing heart failure symptoms for patients with diabetes—helpful to Novo Nordisk as it makes case insurers should pay for the weight-loss medication

26 1
07.04.2024
The blockbuster drug from Novo Nordisk has a list price of about $1,350 per month in the US.

© Fortune


Get it on Google Play